Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NanoViricides Inc | NNVC | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 1.15 | 04:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.15 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 1.00 - 2.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.15 | USD |
NanoViricides Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 13.55M | 11.78M | - | 0 | -8.59M | -0.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
NanoViricides News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NNVC Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.15 | 1.28 | 1.09 | 1.13 | 15,151 | 0.00 | 0.00% |
| 1 Month | 1.12 | 1.50 | 1.09 | 1.28 | 37,232 | 0.03 | 2.68% |
| 3 Months | 1.12 | 1.50 | 1.07 | 1.23 | 30,144 | 0.03 | 2.68% |
| 6 Months | 1.16 | 1.50 | 1.00 | 1.18 | 39,793 | -0.01 | -0.86% |
| 1 Year | 1.27 | 2.00 | 1.00 | 1.34 | 52,801 | -0.12 | -9.45% |
| 3 Years | 4.20 | 7.86 | 1.00 | 4.81 | 338,164 | -3.05 | -72.62% |
| 5 Years | 0.266 | 19.80 | 0.16045 | 7.12 | 688,761 | 0.884 | 332.33% |
NanoViricides Description
| Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy. |
